Insmed (INSM) Asset Utilization Ratio (2011 - 2026)
Insmed's (INSM) quarterly Asset Utilization Ratio came in at 0.38 in Q1 2026, up 89.7% year-on-year from 0.2 in Q1 2025, and up 44.02% quarter-over-quarter from 0.26 in Q4 2025.
Insmed (INSM) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Insmed's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.38 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 89.7% year-over-year to 0.38 in Q1 2026; TTM through Mar 2026 was 0.38, a 89.7% increase from a year earlier, with the FY2025 full-year figure at 0.28, up 30.4% from the prior year.
- Asset Utilization Ratio climbed to 0.38 in Q1 2026 per INSM's latest filing, from 0.26 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.38 in Q1 2026 and bottomed at 0.16 in Q1 2023.
- The 5-year median for Asset Utilization Ratio is 0.2 (2025), against an average of 0.21.
- Across the five-year window, Asset Utilization Ratio retreated 25.46% in 2022 and soared 89.7% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.19 in 2022, then increased by 24.23% to 0.23 in 2023, then dropped by 22.43% to 0.18 in 2024, then soared by 47.01% to 0.26 in 2025, then surged by 44.02% to 0.38 in 2026.
- Per Business Quant, the three latest INSM Asset Utilization Ratio figures stand at 0.38 (Q1 2026), 0.26 (Q4 2025), and 0.18 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.38 |
| Dec 31, 2025 | 0.26 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.20 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.23 |
| Sep 30, 2023 | 0.20 |
| Jun 30, 2023 | 0.18 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.18 |